Peng Gu

Dr. Peng Gu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
PGPeng Gu
Peng Gu
YYYuan Yan
Yuan Yan
HTHao Tang
Hao Tang
YJYanqing Jia
Yanqing Jia
YWYonghao Wen
Yonghao Wen
TWTianlin Wen
Tianlin Wen
Background: Guided exercise is central to rehabilitation for chronic nonspecific low back pain. Telerehabilitation enables remote delivery of guided exercise, but its effectiveness vs other rehabilitation modalities remains uncertain. Objective: This review systematically assessed the comparative efficacy of telerehabilitation, in-person rehabilitation (IPR), and usual care (UC) for improving pain, disability, kinesiophobia, and health-related quality of life in patients with chronic nonspecific low back pain. Telerehabilitation combined with artificial intelligence (TLRH-AI) was evaluated as an exploratory intervention because available evidence was limited. Methods: Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines, we searched randomized controlled trials in PubMed, Cochrane Library, Web of Science, and Embase from inception to April 30, 2026. A Bayesian network meta-analysis was conducted using R (version 4.4.1). Interventions were ranked using surface under the cumulative ranking curve (SUCRA) values. Evidence certainty was assessed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework. Findings were interpreted considering heterogeneity, risk of bias, inconsistency, and estimated prediction intervals. Results: Among 2491 records, 20 randomized controlled trials involving 1854 participants were included. For pain intensity, IPR showed the greatest benefit at 4 weeks (low-certainty evidence), telerehabilitation at 8 weeks (moderate-certainty evidence), and telerehabilitation ranked highest at 12 weeks (SUCRA 87.2%; moderate-certainty evidence). For the Oswestry Disability Index–based disability, IPR ranked highest at 4 weeks (SUCRA 98.2%; low-certainty evidence) and 12 weeks (SUCRA 86.7%; low-certainty evidence), whereas telerehabilitation ranked highest at 8 weeks (SUCRA 90.4%; high-certainty evidence). For the Roland-Morris Disability Questionnaire–based disability, IPR was among the more effective interventions (SUCRA 67.3%; low-certainty evidence). For kinesiophobia, IPR ranked highest (SUCRA 99%; low-certainty evidence). For health-related quality of life, telerehabilitation significantly improved the physical component summary score (mean difference 6.05, 95% credible interval [CrI] 2.89-9.22; moderate-certainty evidence), whereas IPR showed a nonsignificant trend toward an improved mental component summary score (mean difference 2.79, 95% CrI −1.61 to 7.17; low-certainty evidence). Evidence for TLRH-AI remained limited and descriptive, suggesting possible short-term benefits with low to very low certainty. No significant small-study effects or global inconsistency were detected, although potentially important local inconsistency was observed in the 4-week Oswestry Disability Index comparison between UC and IPR. Conclusions: This review uniquely compared telerehabilitation, IPR, UC, and exploratory TLRH-AI within a Bayesian network meta-analysis. Unlike previous reviews focused mainly on telerehabilitation vs conventional care, it provides a comparative hierarchy across delivery models, follow-up windows, and outcomes while incorporating evidence certainty and heterogeneity. The findings support individualized rehabilitation selection. In practice, telerehabilitation may offer a scalable option for longer-term pain relief and physical function improvement, whereas IPR may remain important for supervised functional recovery and psychological support. TLRH-AI remains exploratory and should not guide clinical decision-making until adequately powered trials are available. Trial Registration: PROSPERO CRD420251146712; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251146712

2 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LLLele Liu
Lele Liu
PGPeng Gu
Peng Gu
DXDan Xia
Dan Xia
YWYonghao Wen
Yonghao Wen
BLB.E. Li
B.E. Li
YWYaohong Wu
Yaohong Wu
Nickel-titanium (NiTi) stents have been widely used for the palliative treatment of portal vein tumor thrombi due to their excellent mechanical strength and biocompatibility. However, traditional NiTi implants lack active antitumor functions, which can easily lead to tumor re-invasion and subsequent restenosis. Electro-stimulation (ES)-based ablation therapy offers a controllable physical strategy for local tumor clearance; however, the naturally formed TiO₂ layer on the NiTi surface limits its interfacial electrical activity. In this study, an electro-responsive sorafenib-loaded polypyrrole (PPy) film (NiTi-PPy-S) was fabricated on the NiTi surface via electrochemical deposition. The results indicate that the electrochemically deposited PPy film increases the electrical conductivity of NiTi from approximately 1.3 S cm⁻¹ to 3.4 S cm⁻¹. After loading with sorafenib, NiTi-PPy-S retains good electrochemical responsiveness and exhibits voltage-dependent drug release characteristics. Mechanistically, the antitumor effect is closely associated with ES-triggered Ca²⁺ influx, mitochondrial Ca²⁺ overload, mitochondrial membrane potential collapse, and activation of the Caspase-3 apoptotic pathway. This study demonstrates that electro-responsive PPy can transform passive NiTi implants into active antitumor therapeutic interfaces, providing a promising strategy for the development of multifunc-tional implants for the treatment of portal vein tumor thrombi.

Verified
Journal Article
Open access
PDF file
LLLele Liu
Lele Liu
PGPeng Gu
Peng Gu
DXDan Xia
Dan Xia
YWYonghao Wen
Yonghao Wen
BLB.E. Li
B.E. Li
YWYaohong Wu
Yaohong Wu
Nickel–titanium (NiTi) stents have been widely used for the palliative management of portal vein tumor thrombosis (PVTT) due to their excellent mechanical strength and biocompatibility. However, conventional NiTi implants are therapeutically passive and lack intrinsic antitumor activity, rendering them vulnerable to tumor ingrowth and subsequent restenosis. Electrical stimulation-mediated ablation offers a controllable physical strategy for local tumor clearance; however, the native TiO2 passivation layer on the NiTi surface restricts its interfacial electroactivity. Electrochemical impedance spectroscopy revealed that the PPy coating significantly reduced the interfacial impedance of the NiTi substrate. After loading with sorafenib, NiTi−PPy−S maintained good electrochemical responsiveness and enabled voltage-dependent drug release characteristics. Under an applied potential of 0.9 V for 24 h, approximately 10.522 ± 0.295 μg/cm2 of the loaded sorafenib was released mechanistically, whereas only 0.249 ± 0.171 μg/cm2 was released through passive diffusion over the same period. The antitumor effect is closely associated with ES-triggered Ca2+ influx, mitochondrial Ca2+ overload, loss of mitochondrial membrane potential, and caspase-3-dependent apoptosis. These findings demonstrate that electro-responsive PPy can transform passive NiTi implants into active antitumor therapeutic interfaces, offering a promising strategy for developing multifunctional implants for PVTT treatment.

6 November 2026 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
PGPeng Gu
Peng Gu
RCRongchun Chen
Rongchun Chen
YWYaohong Wu
Yaohong Wu
JZJifeng Zhu
Jifeng Zhu
PFPengyue Fang
Pengyue Fang
QCQin Chen
Qin Chen


7 October 2025 in JMIR Preprints
Verified
Preprint
Open access
PGPeng Gu
Peng Gu
YYYuan Yan
Yuan Yan
HTHao Tang
Hao Tang
YJYanqing Jia
Yanqing Jia
YWYonghao Wen
Yonghao Wen
TWTianlin Wen
Tianlin Wen
BACKGROUND Guided exercise is central to rehabilitation for chronic nonspecific low back pain. Telerehabilitation enables remote delivery of guided exercise, but its effectiveness vs other rehabilitation modalities remains uncertain. OBJECTIVE This review systematically assessed the comparative efficacy of telerehabilitation, in-person rehabilitation (IPR), and usual care (UC) for improving pain, disability, kinesiophobia, and health-related quality of life in patients with chronic nonspecific low back pain. Telerehabilitation combined with artificial intelligence (TLRH-AI) was evaluated as an exploratory intervention because available evidence was limited. METHODS Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines, we searched randomized controlled trials in PubMed, Cochrane Library, Web of Science, and Embase from inception to April 30, 2026. A Bayesian network meta-analysis was conducted using R (version 4.4.1). Interventions were ranked using surface under the cumulative ranking curve (SUCRA) values. Evidence certainty was assessed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework. Findings were interpreted considering heterogeneity, risk of bias, inconsistency, and estimated prediction intervals. RESULTS Among 2491 records, 20 randomized controlled trials involving 1854 participants were included. For pain intensity, IPR showed the greatest benefit at 4 weeks (low-certainty evidence), telerehabilitation at 8 weeks (moderate-certainty evidence), and telerehabilitation ranked highest at 12 weeks (SUCRA 87.2%; moderate-certainty evidence). For the Oswestry Disability Index–based disability, IPR ranked highest at 4 weeks (SUCRA 98.2%; low-certainty evidence) and 12 weeks (SUCRA 86.7%; low-certainty evidence), whereas telerehabilitation ranked highest at 8 weeks (SUCRA 90.4%; high-certainty evidence). For the Roland-Morris Disability Questionnaire–based disability, IPR was among the more effective interventions (SUCRA 67.3%; low-certainty evidence). For kinesiophobia, IPR ranked highest (SUCRA 99%; low-certainty evidence). For health-related quality of life, telerehabilitation significantly improved the physical component summary score (mean difference 6.05, 95% credible interval [CrI] 2.89-9.22; moderate-certainty evidence), whereas IPR showed a nonsignificant trend toward an improved mental component summary score (mean difference 2.79, 95% CrI −1.61 to 7.17; low-certainty evidence). Evidence for TLRH-AI remained limited and descriptive, suggesting possible short-term benefits with low to very low certainty. No significant small-study effects or global inconsistency were detected, although potentially important local inconsistency was observed in the 4-week Oswestry Disability Index comparison between UC and IPR. CONCLUSIONS This review uniquely compared telerehabilitation, IPR, UC, and exploratory TLRH-AI within a Bayesian network meta-analysis. Unlike previous reviews focused mainly on telerehabilitation vs conventional care, it provides a comparative hierarchy across delivery models, follow-up windows, and outcomes while incorporating evidence certainty and heterogeneity. The findings support individualized rehabilitation selection. In practice, telerehabilitation may offer a scalable option for longer-term pain relief and physical function improvement, whereas IPR may remain important for supervised functional recovery and psychological support. TLRH-AI remains exploratory and should not guide clinical decision-making until adequately powered trials are available. CLINICALTRIAL PROSPERO CRD420251146712; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251146712